Login
Home
Charts
Search
Watchlist
Products

Norris Medicines Ltd

NORRIS·BSE
₹18.71-4.98%Wed, 23 Sept '26 12:50
Industry:Pharmaceuticals Bulk Drugs & Formulation
Indices:

Norris Medicines Ltd

NORRIS
BSE
₹18.71
-4.98%
|Wed, 23 Sept '26 12:50
SOICxStockScans Reports
Industry
Pharmaceuticals Bulk Drugs & Formulation
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹19Cr
Close
Close Price
₹18.71
Industry
Industry
Pharmaceuticals Bulk Drugs & Formulation
PE
Price To Earnings
—
PS
Price To Sales
2.46
Revenue
Revenue
₹8Cr
Rev Gr TTM
Revenue Growth TTM
15.85%
PAT Gr TTM
PAT Growth TTM
68.64%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
311111312311
Growth YoY
Revenue Growth YoY%
-15.5-79.423.1-24.2-50.470.882.5102.857.5194.6-48.2-37.0
Expenses
ExpensesCr
311111322211
Operating Profit
Operating ProfitCr
000000000100
OPM
OPM%
-9.8-6.232.9-23.6-11.8-2.72.6-6.8-24.529.122.0-31.5
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
00000000-1100
Tax
TaxCr
000000000000
PAT
PATCr
00000000-1100
Growth YoY
PAT Growth YoY%
14.3-35.0131.539.325.0-3.7-235.316.2-100.0350.0121.7-29.0
NPM
NPM%
-18.8-41.511.4-51.4-28.4-25.2-8.5-21.2-36.021.43.5-43.5
EPS
EPS₹
-0.5-0.30.2-0.4-0.4-0.3-0.2-0.3-0.70.70.1-0.4
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
311111312311
Growth YoY
Revenue Growth YoY%
-15.5-79.423.1-24.2-50.470.882.5102.857.5194.6-48.2-37.0
Expenses
ExpensesCr
311111322211
Operating Profit
Operating ProfitCr
000000000100
OPM
OPM%
-9.8-6.232.9-23.6-11.8-2.72.6-6.8-24.529.122.0-31.5
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
00000000-1100
Tax
TaxCr
000000000000
PAT
PATCr
00000000-1100
Growth YoY
PAT Growth YoY%
14.3-35.0131.539.325.0-3.7-235.316.2-100.0350.0121.7-29.0
NPM
NPM%
-18.8-41.511.4-51.4-28.4-25.2-8.5-21.2-36.021.43.5-43.5
EPS
EPS₹
-0.5-0.30.2-0.4-0.4-0.3-0.2-0.3-0.70.70.1-0.4

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
19201416812986688
Growth
Revenue Growth%
1.08.5-33.719.9-51.856.2-23.0-11.4-32.63.339.715.8
Expenses
ExpensesCr
1821151710141076677
Operating Profit
Operating ProfitCr
10-2-1-2-2010010
OPM
OPM%
4.4-0.4-14.1-3.8-27.5-14.2-0.811.0-3.3-4.58.26.3
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
111112120010
Depreciation
DepreciationCr
111111111100
PBT
PBTCr
0-1-3-2-4-4-2-1-1-100
Tax
TaxCr
00-10-11110000
PAT
PATCr
0-1-3-2-3-5-3-2-1-100
Growth
PAT Growth%
103.6-2,127.2-227.433.3-69.5-74.734.246.432.2-4.377.368.6
NPM
NPM%
0.2-3.8-18.5-10.3-36.2-40.5-34.6-20.9-21.1-21.3-3.5-4.9
EPS
EPS₹
0.0-0.8-2.6-1.7-2.8-5.0-3.3-1.8-1.2-1.2-0.3-0.4
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
19201416812986688
Growth
Revenue Growth%
1.08.5-33.719.9-51.856.2-23.0-11.4-32.63.339.715.8
Expenses
ExpensesCr
1821151710141076677
Operating Profit
Operating ProfitCr
10-2-1-2-2010010
OPM
OPM%
4.4-0.4-14.1-3.8-27.5-14.2-0.811.0-3.3-4.58.26.3
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
111112120010
Depreciation
DepreciationCr
111111111100
PBT
PBTCr
0-1-3-2-4-4-2-1-1-100
Tax
TaxCr
00-10-11110000
PAT
PATCr
0-1-3-2-3-5-3-2-1-100
Growth
PAT Growth%
103.6-2,127.2-227.433.3-69.5-74.734.246.432.2-4.377.368.6
NPM
NPM%
0.2-3.8-18.5-10.3-36.2-40.5-34.6-20.9-21.1-21.3-3.5-4.9
EPS
EPS₹
0.0-0.8-2.6-1.7-2.8-5.0-3.3-1.8-1.2-1.2-0.3-0.4

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1010101010101010101010
Reserves
ReservesCr
-5-5-8-10-12-17-21-22-24-25-25
Current Liabilities
Current LiabilitiesCr
5101198127891010
Non Current Liabilities
Non Current LiabilitiesCr
7881115161818191919
Total Liabilities
Total LiabilitiesCr
1822212021201414141413
Current Assets
Current AssetsCr
79877845666
Non Current Assets
Non Current AssetsCr
111313131312109877
Total Assets
Total AssetsCr
1822212021201414141413
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1010101010101010101010
Reserves
ReservesCr
-5-5-8-10-12-17-21-22-24-25-25
Current Liabilities
Current LiabilitiesCr
5101198127891010
Non Current Liabilities
Non Current LiabilitiesCr
7881115161818191919
Total Liabilities
Total LiabilitiesCr
1822212021201414141413
Current Assets
Current AssetsCr
79877845666
Non Current Assets
Non Current AssetsCr
111313131312109877
Total Assets
Total AssetsCr
1822212021201414141413

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1-11-2-31-11011
Investing Cash Flow
Investing Cash FlowCr
0-2000000000
Financing Cash Flow
Financing Cash FlowCr
-13-123-11-10-1-1
Net Cash Flow
Net Cash FlowCr
00000000000
Free Cash Flow
Free Cash FlowCr
1-31-2-31-11001
CFO To PAT
CFO To PAT%
3,562.7125.3-31.7114.3101.5-22.430.9-68.6-14.3-41.2-208.7
CFO To EBITDA
CFO To EBITDA%
161.61,274.6-41.5312.3133.8-63.81,404.5130.1-91.8-194.188.1
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1-11-2-31-11011
Investing Cash Flow
Investing Cash FlowCr
0-2000000000
Financing Cash Flow
Financing Cash FlowCr
-13-123-11-10-1-1
Net Cash Flow
Net Cash FlowCr
00000000000
Free Cash Flow
Free Cash FlowCr
1-31-2-31-11001
CFO To PAT
CFO To PAT%
3,562.7125.3-31.7114.3101.5-22.430.9-68.6-14.3-41.2-208.7
CFO To EBITDA
CFO To EBITDA%
161.61,274.6-41.5312.3133.8-63.81,404.5130.1-91.8-194.188.1

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
176371014171319
Price To Earnings
Price To Earnings
Price To Sales
Price To Sales
1.20.40.40.51.32.42.91.62.5
Price To Book
Price To Book
8.115.9-1.1-0.9-0.8-1.0-1.1-0.9-1.2
EV To EBITDA
EV To EBITDA
-12.7-28.0-8.2-12.634.5-189.7-145.852.584.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
36.032.631.124.220.817.729.144.636.026.836.436.4
OPM
OPM%
4.4-0.4-14.1-3.8-27.5-14.2-0.811.0-3.3-4.58.26.3
NPM
NPM%
0.2-3.8-18.5-10.3-36.2-40.5-34.6-20.9-21.1-21.3-3.5-4.9
ROCE
ROCE%
4.2-4.8-25.5-11.1-22.4-29.1-6.83.4-9.2-11.03.43.4
ROE
ROE%
0.7-16.8-122.6-449.8115.166.830.514.18.78.31.91.9
ROA
ROA%
0.2-3.5-12.1-8.2-13.8-25.1-23.0-12.8-8.4-9.0-2.2-2.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
176371014171319
Price To Earnings
Price To Earnings
Price To Sales
Price To Sales
1.20.40.40.51.32.42.91.62.5
Price To Book
Price To Book
8.115.9-1.1-0.9-0.8-1.0-1.1-0.9-1.2
EV To EBITDA
EV To EBITDA
-12.7-28.0-8.2-12.634.5-189.7-145.852.584.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
36.032.631.124.220.817.729.144.636.026.836.436.4
OPM
OPM%
4.4-0.4-14.1-3.8-27.5-14.2-0.811.0-3.3-4.58.26.3
NPM
NPM%
0.2-3.8-18.5-10.3-36.2-40.5-34.6-20.9-21.1-21.3-3.5-4.9
ROCE
ROCE%
4.2-4.8-25.5-11.1-22.4-29.1-6.83.4-9.2-11.03.43.4
ROE
ROE%
0.7-16.8-122.6-449.8115.166.830.514.18.78.31.91.9
ROA
ROA%
0.2-3.5-12.1-8.2-13.8-25.1-23.0-12.8-8.4-9.0-2.2-2.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Norris Medicines Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/ooasv448r128n15kmeblzyvo.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/8k25sfl91kyue4lygw37i6za.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/ciydqukj6mqz1m9qmpt47ofs.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/wb6g4y505tams1fwpwee7imy.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/cc4o31jk5dvb8axe1utwmd1p.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/q6j36h8etpr6cqjs2yadq12v.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/qxsfxey1ea8iz6y3nzv1l41u.pdf
  • Q4 FY2024 Quarterly Result (Mar 2024, PDF): https://www.stockscans.in/document/haxuo6wrehxbq7lpwbvqkp2p.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/9i6qyuvv3vtunyyr6vqzxw17.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/or1qk7cbelqb4opcna840erv.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/kktzkrx55bn19qzgmgxlbmuh.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/tlr8wws48jwzv8v82u2hiuvw.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/9fam37wcc0cbo520otfc1yi7.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/1arcltmvimqvltafjx5l8w9m.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/0ggenmci3w0e32vro1zeace4.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies